The comprehensive criteria encompasses evaluation of debt management, sales growth, earnings-per-share performance, as well as returns on equity
This investment will be made by Caplin Point Laboratories Limited and its subsidiaries - Caplin Steriles Limited and Caplin One Labs Limited
Thiamine Hydrochloride Injection is effective in the treatment of vitamin B1 deficiency (beriberi)
Rocuronium Bromide Injection is a neuromuscular blocking agent
The company is the Clinical Research Organisation of Caplin Point Laboratories
The approval allows it to market its products in the country
Subscribe To Our Newsletter & Stay Updated
